We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current NCNA market cap is 209.06M. The company's latest EPS is GBP -0.5234 and P/E is -7.57.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -9.1M | -15.02M | -8.45M | -5.71M | -8.81M |
Net Income | -4.53M | -15.2M | -7.87M | -5.41M | -6.7M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -25.68M | -32.95M | -48.17M | -44.01M | -31.63M |
Net Income | -21.41M | -30.68M | -40.53M | -32.02M | -27.63M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 68.66M | 58.25M | 48.75M | 41.26M | 33.97M |
Total Liabilities | 15.96M | 19.75M | 17M | 13.88M | 12.19M |
Total Equity | 52.69M | 38.5M | 31.75M | 27.38M | 21.77M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 70.27M | 107.79M | 77.47M | 58.25M | 27.81M |
Total Liabilities | 6.75M | 8.56M | 11.93M | 19.75M | 12.92M |
Total Equity | 63.52M | 99.23M | 65.55M | 38.5M | 14.89M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -16.37M | -23.16M | -10.34M | -16.19M | -26.36M |
Investing | -40k | 120k | 163k | 186k | 2.84M |
Financing | -188k | -161k | -41k | -74k | -10k |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -23.83M | -21.62M | -23.82M | -23.16M | -26.44M |
Investing | -145k | -1.31M | -3.56M | 120k | 2.89M |
Financing | -47k | 61.8M | -98k | -161k | -53k |
Market Cap | 209.06M |
Price to Earnings Ratio | -7.57 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 12.14 |
Price to Book Ratio | 14.04 |
Dividend Yield | - |
Shares Outstanding | 52.79M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.48 (11.06%) |
Company Name | NuCana PLC |
Address |
77/78 cannon street london EC4N 6AF |
Website | https://www.nucana.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions